Breaking News

Celerion Opens South Korea Ops

By Kristin Brooks | March 4, 2014

Partnership with Seoul University Hospital provides access to 80-bed research unit

Celerion has expanded its clinical operations to South Korea through a partnership with Seoul National University Hospital (SNUH). The new office is located within the SNUH Clinical Trials Center and provides Celerion with access to the 80-bed clinical research unit specializing in clinical pharmacology, oncology, and pediatrics, as well as to the center’s staff. John Horkulak, executive director, Eurasian Site Operations will oversee the new office. Mr. Horkulak has more than 20 years of experience in managing clinical pharmacology studies in patient populations.
The SNUH Clinical Trials Center focuses on translational medicine and supports Celerion’s strategic objective to provide global services for the growing interest in complex early clinical studies, often involving patients. Additionally, Celerion has audited three other clinical trial centers in South Korea to support multi-site early clinical studies in patients.
“We are very pleased to have a presence in South Korea through our partnership with Seoul National University Hospital,” said Susan Thornton Ph.D., president and chief executive officer at Celerion. “They are a highly respected institution and among the global leaders in the conduct of quality medical research. Collectively, we are in a solid position to successfully conduct and analyze complex clinical pharmacology studies involving patients with access to specialized equipment and facilities.”
“It is an honor for us to partner with Celerion, a global leader in early clinical research,” said Prof. Yung-Jue Bang MD Ph.D., president of the Biomedical Research Institute at SNUH, who also serves as the Director to the Clinical Trials Center. “The partnership enables us to participate more actively in global drug development programs as well as supporting the early clinical research needs for the emerging Korean drug discovery industry.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important